BETA
Your AI-Trained Oncology Knowledge Connection!
Oncologists were among the first practitioners to embrace mobile technologies. We present the top 10 oncology apps for iPhone, iPad, and Android devices.
Stay up to date on recent advances in the multidisciplinary approach to cancer.
AI-Based Urine Test Earns FDA Breakthrough Device Status in Bladder Cancer
Use of the novel artificial intelligence–based test may provide a painless, low-cost alternative in bladder cancer screening.
Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis
Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.
High Tumor Volume Confers CAR T-Cell Therapy Toxicity Risk in LBCL
Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.
Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting
Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.
89Zr-DFO-daratumumab Has Potential Imaging Benefits in Non-FDG–Avid Multiple Myeloma
89Zr-DFO-daratumumab shows activity in identifying and localizing multiple myeloma, even in FDG-non-avid cases, per new phase 2 data.
Serplulimab Earns UK Approval in Extensive-Stage Small Cell Lung Cancer
Data from the phase 3 ASTRUM-005 trial support the MHRA’s approval of serplulimab for patients with extensive-stage small cell lung cancer.